Applications, hearings, determinations, etc.: Ansys Diagnostics, Inc.,

Text

---

Federal Register: October 9, 1998 (Volume 63, Number 196)NoticesPage 54490-54491From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr09oc98-151

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 5, 1998, Ansys Diagnostics, Inc., 25200 Commercentre Drive, Lake Forest, California 92630, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Phencyclidine (7471)........................ II 1-Piperidinocyclohexanecarbonitrile (PCC) II (8603). Benzoylecgonine (9180)...................... II

The firm plans to manufacture the listed controlled substances to produce standards and controls for in-vitro diagnostic drug testing systems.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than December 8, 1998.

[Page 54491]

Dated: October 1, 1998. John H. King, Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement Administration.

FR Doc. 98-27100Filed10-8-98; 8:45 amBILLING CODE 4410-09-M

---